Jazz Pharmaceuticals Completes Acquisition of EUSA Pharma

June 12, 2012

Cahill represented Barclays Bank PLC as administrative agent and lead arranger in connection with a $575,000,000 senior secured credit facility for Jazz Pharmaceuticals, Inc., comprised of a $475,000,000 term loan facility and a $100,000,000 revolving credit facility. The proceeds from the term loan facility were used to acquire EUSA Pharma Inc., and the revolving credit facility will be available for general corporate purposes.